Literature DB >> 15121745

Daily short-period gravitation can prevent functional and structural changes in arteries of simulated microgravity rats.

Biao Sun1, Li-Fan Zhang, Fang Gao, Xiao-Wu Ma, Miao-Li Zhang, Jian Liu, Le-Ning Zhang, Jin Ma.   

Abstract

This study was designed to clarify whether simulated microgravity-induced differential adaptational changes in cerebral and hindlimb arteries could be prevented by daily short-period restoration of the normal distribution of transmural pressure across arterial vasculature by either dorsoventral or footward gravitational loading. Tail suspension (Sus) for 28 days was used to simulate cardiovascular deconditioning due to microgravity. Daily standing (STD) for 1, 2, or 4 h, or +45 degrees head-up tilt (HUT) for 2 or 4 h was used to provide short-period dorsoventral or footward gravitational loading as countermeasure. Functional studies showed that Sus alone induced an enhancement and depression in vasoconstrictor responsiveness of basilar and femoral arterial rings, respectively, as previously reported. These differential functional alterations can be prevented by either of the two kinds of daily gravitational loading treatments. Surprisingly, daily STD for as short as 1 h was sufficient to prevent the differential functional changes that might occur due to Sus alone. In morphological studies, the effectiveness of daily 4-h HUT or 1-h STD in preventing the differential remodeling changes in the structure of basilar and anterior tibial arteries induced by Sus alone was examined by histomorphometry. The results showed that both the hypertrophic and atrophic changes that might occur, respectively, in cerebral and hindlimb arteries due to Sus alone were prevented not only by daily HUT for 4 h but also by daily STD even for 1 h. These data indicate that daily gravitational loading by STD for as short as 1 h is sufficient to prevent differential adaptational changes in function and structure of vessels in different anatomic regions induced by a medium-term simulated microgravity.

Entities:  

Mesh:

Year:  2004        PMID: 15121745     DOI: 10.1152/japplphysiol.00188.2004

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  The therapeutic benefits of gravity in space and on earth.

Authors:  C Kourtidou-Papadeli; C L Papadelis; J Vernikos; P D Bamidis; M Hitoglou-Antoniadou; E Perantoni; E Vlachogiannis
Journal:  Hippokratia       Date:  2008-08       Impact factor: 0.471

2.  Spaceflight on the Bion-M1 biosatellite alters cerebral artery vasomotor and mechanical properties in mice.

Authors:  Svetlana I Sofronova; Olga S Tarasova; Dina Gaynullina; Anna A Borzykh; Bradley J Behnke; John N Stabley; Danielle J McCullough; Joshua J Maraj; Mina Hanna; Judy M Muller-Delp; Olga L Vinogradova; Michael D Delp
Journal:  J Appl Physiol (1985)       Date:  2015-01-15

Review 3.  Region-specific vascular remodeling and its prevention by artificial gravity in weightless environment.

Authors:  Li-Fan Zhang
Journal:  Eur J Appl Physiol       Date:  2013-03-24       Impact factor: 3.078

4.  The Effect of Reloading on Disuse Muscle Atrophy: Time Course of Hypertrophy and Regeneration Focusing on the Myofiber Cross-sectional Area and Myonuclear Change.

Authors:  Kazumi Zushi; Toshiaki Yamazaki
Journal:  J Jpn Phys Ther Assoc       Date:  2012

5.  Spaceflight-induced alterations in cerebral artery vasoconstrictor, mechanical, and structural properties: implications for elevated cerebral perfusion and intracranial pressure.

Authors:  Curtis R Taylor; Mina Hanna; Bradley J Behnke; John N Stabley; Danielle J McCullough; Robert T Davis; Payal Ghosh; Anthony Papadopoulos; Judy M Muller-Delp; Michael D Delp
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

6.  Mechanics and composition of middle cerebral arteries from simulated microgravity rats with and without 1-h/d -Gx gravitation.

Authors:  Jiu-Hua Cheng; Li-Fan Zhang; Fang Gao; Yun-Gang Bai; Marco Boscolo; Xiao-Feng Huang; Xiang Zhang
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.